Carnivore Diet for Health & Longevity - Quick Reference Sheet

Carnivore Diet for Health & Longevity

Created on 07/29/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Built entirely from animal foods, the carnivore diet reliably drives short-term weight and fat loss, curbs appetite, and lowers blood sugar, and appears to ease stubborn digestive and autoimmune symptoms for some. Cholesterol usually rises, sometimes sharply, and long-term effects on heart disease and lifespan remain unknown. Evidence is thin, so close self-monitoring separates a reasonable experiment from a gamble. (Full Review)

Protocol

Core Foods
Animal foods only
Fatty ruminant meat (beef, lamb), eggs, fish, often butter or hard cheese, plus salt and water
Intake
Eat to satiety
Enough fat to feel satisfied; no counting of calories or macronutrients
Meal Timing
Left to appetite
Many adherents settle on one or two large meals per day
Time to effect
Weight & Appetite
1–2 weeks
Weight and appetite changes often appear
Symptom Relief
Weeks to months
Digestive or autoimmune symptom improvement
Adaptation
2–6 weeks
Possible fatigue and digestive upset before energy stabilizes

Benefits

Contraindications
  • Familial hypercholesterolemia
  • Advanced chronic kidney disease (CKD stage 4–5)
  • History of eating disorders
  • Inherited fat-oxidation disorders (e.g., carnitine palmitoyltransferase deficiency)
  • Pregnancy and lactation
  • Children
Key Interactions
  • Glucose-lowering medications (insulin, sulfonylureas such as glipizide, glyburide)
  • SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin)
  • Antihypertensive drugs (diuretics, ACE inhibitors such as lisinopril)
  • Warfarin
  • NSAIDs (ibuprofen, naproxen)
  • Electrolyte supplements (sodium, potassium, magnesium); high-dose vitamin A or iron
  • Other ketogenic, fasting, or very-low-carbohydrate protocols

Risk & Side Effects

  • High: Elevated LDL cholesterol and ApoB
  • Medium: Cardiovascular disease risk from red and processed meat; colorectal and other cancer risk; micronutrient and fiber inadequacy; digestive disturbance during adaptation
  • Low: Gout and kidney stone risk; gut microbiome disruption
  • Speculative: Long-term all-cause mortality uncertainty; TMAO-mediated atherogenic risk

Monitoring

Marker Target Why
ApoB < 80 mg/dL Best single measure of artery-clogging particle burden
LDL cholesterol < 100 mg/dL Main cholesterol fraction linked to artery disease
Triglycerides < 80 mg/dL Reflects carbohydrate and metabolic status
Fasting glucose 70–90 mg/dL Tracks blood-sugar control
HbA1c 4.8–5.4% Average blood sugar over ~3 months
hs-CRP < 1.0 mg/L General marker of body-wide inflammation
Uric acid 3.5–6.0 mg/dL Gout and kidney-stone risk
eGFR > 90 mL/min/1.73m² Kidney function under a high-protein load
Ferritin 30–150 ng/mL Iron stores; overload risk on heavy red meat

Cadence: Baseline, then 4–8 weeks after starting, again at 3–6 months, and every 6–12 months thereafter; more frequent lipid checks if cholesterol rises sharply

Qualitative Assessment

  • Energy levels and freedom from mid-adaptation fatigue
  • Digestive comfort (bloating, regularity, pain)
  • Sleep quality and duration
  • Mood, anxiety, and mental clarity
  • Hunger, cravings, and satiety between meals
  • Physical performance and recovery
  • Skin, joint, and autoimmune-symptom changes